Teclistamab Significantly Improves Survival Among Patients with Multiple Myeloma Who Previously Received One To Three Lines of Treatment By Ogkologos - June 16, 2026 151 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the MajesTEC-9 study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Pesticide Usage, in Particular of Picloram, Associated with Early Onset Colorectal... May 4, 2026 Vaping Pods Produce High Nicotine Levels in Young Users October 5, 2018 Pembrolizumab Provides First-Ever Overall Survival Improvement in Kidney Cancer May 21, 2024 The Taylor Family Foundation gives £2.1m to support head and neck... December 12, 2022 Load more HOT NEWS African American Men More Likely to Die from Low-Grade Prostate Cancer Whole-Genome Sequencing Could Help Guide AML Treatment Cetuximab Outperforms Durvalumab for Head and Neck Cancer When Cisplatin Isn’t... Perioperative Chemotherapy with FLOT Improves Survival Among Patients with Resectable Oesophageal...
